gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Uterine Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bae, DS; Keserci, B; Kim, BG; Kim, JH; Kim, TJ; Kim, YS; Köhler, MO; Lee, JH; Lee, JW; Lim, HK; Park, BK; Rhim, H; Sokka, S | 1 |
1 trial(s) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Uterine Neoplasms
Article | Year |
---|---|
Dynamic contrast-enhanced magnetic resonance imaging predicts immediate therapeutic response of magnetic resonance-guided high-intensity focused ultrasound ablation of symptomatic uterine fibroids.
Topics: Adult; Contrast Media; Female; Heterocyclic Compounds; High-Intensity Focused Ultrasound Ablation; Humans; Least-Squares Analysis; Leiomyoma; Linear Models; Magnetic Resonance Imaging; Magnetic Resonance Imaging, Interventional; Middle Aged; Organometallic Compounds; Predictive Value of Tests; Prospective Studies; Treatment Outcome; Uterine Neoplasms | 2011 |